“Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16”, J of Skin, vol. 9, no. 6, p. s636, Nov. 2025, doi: 10.25251/57ey8s02.